SCHEMBL21391275

SCHEMBL21391275

CC(C)(Oc1ccc(C(=O)c2cccc(Cl)c2)cc1)C(=O)Cl

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PPARA Q07869 6/20 0.57
PPARG P37231 5/20 0.57
FABP2 P12104 1/20 0.57
SLC22A12 Q96S37 1/20 0.57
CYP2C19 P33261 3/20 0.51
CYP1A2 P05177 3/20 0.51
CYP3A4 P08684 3/20 0.51
SLC6A2 P23975 3/20 0.51
MEN1 O00255 2/20 0.51
MAPT P10636 2/20 0.51
KMT2A Q03164 2/20 0.51
HPGD P15428 2/20 0.51
SLC6A3 Q01959 2/20 0.51
BLM P54132 2/20 0.51
SMN1; SMN2 Q16637 2/20 0.51
ABCB11 O95342 2/20 0.51
TSHR P16473 2/20 0.51
HTR2A P28223 2/20 0.51
PMP22 Q01453 2/20 0.51
USP2 O75604 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21378829 0.89 PPARG (0.74) PPARAPPARGFABP2SLC22A12CYP2C19
SCHEMBL822492 0.85 PPARA (0.77) PPARAPPARGFABP2SLC22A12CYP2C19
SCHEMBL9588829 0.81 HSD11B1 (0.49) PPARAPPARGFABP2SLC22A12CYP2C19
SCHEMBL21391273 0.80 SMN1; SMN2 (0.51) PPARAPPARGFABP2SLC22A12CYP2C19
SCHEMBL8406665 0.79 HPGD (0.69) MEN1MAPTKMT2AHPGDSMN1; SMN2
SCHEMBL11377777 0.79 PPARG (0.58) PPARAPPARGFABP2SLC22A12CYP2C19
SCHEMBL3677325 0.79 SRD5A2 (0.53) HPGDATMTDP1PARP1ALOX15
SCHEMBL3445668 0.78 PARP1 (0.63) MAPK1ATMTDP1VNN1PARP1
SCHEMBL11433076 0.78 TSHR (0.48) PPARAPPARGFABP2SLC22A12CYP2C19
SCHEMBL135713 0.77 PPARA (0.72) PPARAPPARGFABP2SLC22A12CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10647673-B2 Acetophenone compound, preparation method thereof, and application thereof in fatty liver prevention and treatment Nanjing Bioenergy Medicine Science & Technology Co., Ltd. (CN) 2020-05-12 US disclosed
US-20190292153-A1 Acetophenone Compound, Preparation Method Thereof, And Application Thereof In Fatty Liver Prevention And Treatment Nanjing Bioenergy Medicine Science & Technology Co., Ltd. (CN) 2019-09-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10647673-B2 Acetophenone compound, preparation method thereof, and application thereof in fatty liver prevention and treatment LIPC, CYP27A1, HSD17B10 PPARA 14/4885PPARG 32/4885FABP2 164/4885
US-20190292153-A1 Acetophenone Compound, Preparation Method Thereof, And Application Thereof In Fatty Liver Prevention And Treatment LIPC, CYP27A1, HSD17B10 PPARA 14/4885PPARG 32/4885FABP2 164/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.